# Propaten Randomized Investigation on Cost-benefit and Efficacy

> **NCT01601873** · NA · TERMINATED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 103 (actual)

## Conditions studied

- End-stage Renal Disease

## Interventions

- **DEVICE:** PROPATEN
- **DEVICE:** Standard Graft

## Key facts

- **NCT ID:** NCT01601873
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11-09
- **Primary completion:** 2017-12-31
- **Final completion:** 2018-06-30
- **Target enrollment:** 103 (ACTUAL)
- **Why stopped:** Results from futility analysis conducted at planned interim time-point did not meet the study criteria for continuation.
- **Last updated:** 2019-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01601873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01601873, "Propaten Randomized Investigation on Cost-benefit and Efficacy". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01601873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*